Your browser doesn't support javascript.
Shanghai expert consensus on clinical protocol for traditional Chinese medicine treatment of COVID-19 among the elderly population (second edition).
Chen, Xuan; Han, Chou-Ping; Zhang, Wei.
  • Chen X; Department of Respiratory and Critical Care Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Han CP; International Education College, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Zhang W; Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: zhangw1190@sina.com.
J Integr Med ; 20(5): 427-431, 2022 09.
Article in English | MEDLINE | ID: covidwho-1882265
ABSTRACT
This document is the revised edition of the previously issued Shanghai Expert Consensus on Clinical Protocol for Traditional Chinese Medicine Treatment of COVID-19 among the Elderly Population. Based on the clinical experience and the Protocol for Diagnosis and Treatment of COVID-19 (Trial 9th Edition), this revised edition provides treatment approaches and recommendations to proactively cope with Omicron variant and increase the therapeutic efficacy for coronavirus disease 2019 among the elderly population in Shanghai, China.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Medicine, Chinese Traditional Type of study: Prognostic study / Randomized controlled trials Topics: Traditional medicine / Variants Limits: Aged / Humans Country/Region as subject: Asia Language: English Journal: J Integr Med Year: 2022 Document Type: Article Affiliation country: J.joim.2022.06.001

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Medicine, Chinese Traditional Type of study: Prognostic study / Randomized controlled trials Topics: Traditional medicine / Variants Limits: Aged / Humans Country/Region as subject: Asia Language: English Journal: J Integr Med Year: 2022 Document Type: Article Affiliation country: J.joim.2022.06.001